Table 1

Multivariable analysis of impact of mismatch pairs for sever aGVHD in HLA-A and -C

Mismatch combination, donor-patientNHR (95% CI)P
A locus match 4510 NA 
    A0201-A0206 138 1.23 (0.87-1.73) .223 
    A0206-A0201 131 1.78 (1.32-2.41) < .001 
    A0201-A0207 28 0.83 (0.34-2.03) .699 
    A0207-A0201 20 1.12 (0.42-3.02) .809 
    A0201-A0210 11 1.57 (0.58-4.23) .367 
    A0206-A0207 27 3.45 (2.09-5.70) < .001 
    A0207-A0206 22 0.71 (0.23-2.24) .571 
    A2402-A2420 60 0.64 (0.32-1.30) .225 
    A2420-A2402 30 1.18 (0.56-2.49) .66 
    A2601-A2602 24 0.64 (0.26-1.58) .34 
    A2602-A2601 21 3.35 (1.89-5.91) < .001 
    A2601-A2603 34 1.37 (0.73-2.57) .326 
    A2603-A2601 35 2.17 (1.29-3.64) .003 
    A2602-A2603 10 1.23 (0.30-4.98) .763 
    A2603-A2602 12 1.50 (0.48-4.68) .485 
    A other mismatch 97 1.47 (1.00-2.15) .047 
C locus match 3685 NA 
    C0102-C0303 30 2.83 (1.50-5.32) .001* 
    C0303-C0102 38 1.05 (0.47-2.36) .899 
    C0102-C0304 12 1.85 (0.59-5.81) .287 
    C0304-C0102 19 0.89 (0.28-2.79) .854 
    C0102-C0401 14 1.87 (0.77-4.55) .164 
    C0102-C0803 24 1.97 (0.87-4.42) .099 
    C0803-C0102 10 1.66 (0.53-5.19) .383 
    C0102-C1402 16 3.86 (1.98-7.51) < .001* 
    C1402-C0102 13 0.46 (0.06-3.33) .45 
    C0303-C0304 83 1.08 (0.63-1.85) .761 
    C0304-C0303 62 0.83 (0.41-1.68) .614 
    C0303-C0401 31 1.73 (0.89-3.36) .103 
    C0401-C0303 42 2.81 (1.72-4.60) < .001 
    C0303-C0702 25 1.16 (0.52-2.62) .706 
    C0702-C0303 18 2.16 (0.96-4.85) .062 
    C0303-C0801 76 1.07 (0.63-1.84) .782 
    C0801-C0303 80 2.32 (1.58-3.40) < .001 
    C0303-C1502 25 3.22 (1.75-5.89) < .001 
    C0304-C0401 15 3.02 (1.34-6.79) .007 
    C0401-C0304 12 6.22 (3.07-12.5) < .001* 
    C0304-C0702 26 2.35 (1.16-4.76) .017 
    C0702-C0304 33 1.22 (0.58-2.59) .59 
    C0304-C0801 69 2.34 (1.55-3.52) < .001 
    C0801-C0304 47 1.64 (0.98-2.76) .057 
    C0304-C1402 28 3.06 (1.68-5.60) < .001* 
    C1402-C0304 23 3.66 (2.00-6.68) < .001 
    C0304-C1502 53 1.82 (1.08-3.05) .023 
    C1502-C0304 27 3.77 (2.20-6.47) < .001 
    C0801-C0102 10 2.88 (0.92-9.03) .068 
    C0801-C0803 27 1.55 (0.69-3.48) .284 
    C0803-C0801 26 2.04 (1.04-3.99) .037 
    C0801-C1502 36 1.59 (0.79-3.21) .19 
    C1502-C0801 23 2.28 (1.07-4.85) .031 
    C1402-C1502 55 1.67 (1.01-2.77) .043 
    C1502-C1402 50 4.97 (3.41-7.25) < .001 
    C other mismatch 347 1.69 (1.34-2.14) < .001 
Mismatch combination, donor-patientNHR (95% CI)P
A locus match 4510 NA 
    A0201-A0206 138 1.23 (0.87-1.73) .223 
    A0206-A0201 131 1.78 (1.32-2.41) < .001 
    A0201-A0207 28 0.83 (0.34-2.03) .699 
    A0207-A0201 20 1.12 (0.42-3.02) .809 
    A0201-A0210 11 1.57 (0.58-4.23) .367 
    A0206-A0207 27 3.45 (2.09-5.70) < .001 
    A0207-A0206 22 0.71 (0.23-2.24) .571 
    A2402-A2420 60 0.64 (0.32-1.30) .225 
    A2420-A2402 30 1.18 (0.56-2.49) .66 
    A2601-A2602 24 0.64 (0.26-1.58) .34 
    A2602-A2601 21 3.35 (1.89-5.91) < .001 
    A2601-A2603 34 1.37 (0.73-2.57) .326 
    A2603-A2601 35 2.17 (1.29-3.64) .003 
    A2602-A2603 10 1.23 (0.30-4.98) .763 
    A2603-A2602 12 1.50 (0.48-4.68) .485 
    A other mismatch 97 1.47 (1.00-2.15) .047 
C locus match 3685 NA 
    C0102-C0303 30 2.83 (1.50-5.32) .001* 
    C0303-C0102 38 1.05 (0.47-2.36) .899 
    C0102-C0304 12 1.85 (0.59-5.81) .287 
    C0304-C0102 19 0.89 (0.28-2.79) .854 
    C0102-C0401 14 1.87 (0.77-4.55) .164 
    C0102-C0803 24 1.97 (0.87-4.42) .099 
    C0803-C0102 10 1.66 (0.53-5.19) .383 
    C0102-C1402 16 3.86 (1.98-7.51) < .001* 
    C1402-C0102 13 0.46 (0.06-3.33) .45 
    C0303-C0304 83 1.08 (0.63-1.85) .761 
    C0304-C0303 62 0.83 (0.41-1.68) .614 
    C0303-C0401 31 1.73 (0.89-3.36) .103 
    C0401-C0303 42 2.81 (1.72-4.60) < .001 
    C0303-C0702 25 1.16 (0.52-2.62) .706 
    C0702-C0303 18 2.16 (0.96-4.85) .062 
    C0303-C0801 76 1.07 (0.63-1.84) .782 
    C0801-C0303 80 2.32 (1.58-3.40) < .001 
    C0303-C1502 25 3.22 (1.75-5.89) < .001 
    C0304-C0401 15 3.02 (1.34-6.79) .007 
    C0401-C0304 12 6.22 (3.07-12.5) < .001* 
    C0304-C0702 26 2.35 (1.16-4.76) .017 
    C0702-C0304 33 1.22 (0.58-2.59) .59 
    C0304-C0801 69 2.34 (1.55-3.52) < .001 
    C0801-C0304 47 1.64 (0.98-2.76) .057 
    C0304-C1402 28 3.06 (1.68-5.60) < .001* 
    C1402-C0304 23 3.66 (2.00-6.68) < .001 
    C0304-C1502 53 1.82 (1.08-3.05) .023 
    C1502-C0304 27 3.77 (2.20-6.47) < .001 
    C0801-C0102 10 2.88 (0.92-9.03) .068 
    C0801-C0803 27 1.55 (0.69-3.48) .284 
    C0803-C0801 26 2.04 (1.04-3.99) .037 
    C0801-C1502 36 1.59 (0.79-3.21) .19 
    C1502-C0801 23 2.28 (1.07-4.85) .031 
    C1402-C1502 55 1.67 (1.01-2.77) .043 
    C1502-C1402 50 4.97 (3.41-7.25) < .001 
    C other mismatch 347 1.69 (1.34-2.14) < .001 

A0206-A0201 mismatch combination meant that the donor has HLA-A*0206, recipient has HLA-A*0201 and another HLA-A allele of each donor and recipient was identical. Each mismatch pair in HLA-A was compared with the HLA-A allele match, and each mismatch pair in HLA-C was compared with the HLA-C allele match. Confounders considered were sex (donor-recipient pairs), patient age (linear), donor age (linear), type of disease, risk of leukemia relapse (standard, high and diseases other than leukemia), GVHD prophylaxis, (CSP vs. FK), ATG (ATG vs. no ATG) and preconditioning (TBI vs non-TBI).

HR denotes hazard ratio; CI, confidence interval; NA, not applicable.

*

The result of base analysis was significant, but the result of validating analysis using bootstrap resampling was not. The results of the analysis were thus judged not to be statistically significant.

or Create an Account

Close Modal
Close Modal